95 results
8-K
EX-99.1
RIOT
Riot Platforms Inc
8 Jul 08
Departure of Directors or Principal Officers
12:00am
independently.
Merson is a highly seasoned health care executive, having founded and managed several healthcare organizations, from hospitals to health … consulting services to primarily healthcare related enterprises, focusing on mergers and acquisitions, goal setting, business and governance issues
8-K
EX-99.1
RIOT
Riot Platforms Inc
24 May 12
AspenBio Appoints Diagnostics Industry Veteran Don Hurd
12:00am
; Vice President North American Customer Operations, Siemens Healthcare Diagnostics; and U.S. Director of Sales, Bayer Healthcare Diagnostics.
Steve … arising from the use of CT scans performed in triaging pediatric and adolescent patients with abdominal pain, as well as potentially reduce healthcare
424B2
RIOT
Riot Platforms Inc
7 Oct 09
Prospectus for primary offering
12:00am
”) imaging studies performed to rule out a diagnosis of acute appendicitis.
Animal Healthcare
Through our single-chain gonadotropin platform technology we … licensed from Washington University in St. Louis and further developed at AspenBio, we are developing animal healthcare products focused
8-K
RIOT
Riot Platforms Inc
26 Dec 07
Unregistered Sales of Equity Securities
12:00am
for human and animal healthcare. Using our proprietary protein purifying methods, we discovered several blood markers that seem to correlate … . Our primary animal healthcare product known as StayBred™, which is a recombinant single-chain hormone designed to help improve pregnancy rates
424B3
RIOT
Riot Platforms Inc
15 Aug 13
Prospectus supplement
12:00am
for our products under development, as well as a changing regulatory and reimbursement environment, may impact our business.
The U.S. healthcare … care, and similar healthcare management organizations, or reimbursed by government health payor administration authorities, private health coverage
8-K
yi11y7uipzxg
24 May 12
AspenBio Appoints Diagnostics Industry Veteran Don Hurd
12:00am
8-K
EX-99.1
0hxh65npu63mb4luk4x4
10 Aug 09
Regulation FD Disclosure
12:00am
8-K
EX-99.1
h8q6v1 lz
19 Jul 11
Other Events
12:00am
8-K
EX-99.1
kodeyzyl
25 Jan 05
Entry into a Material Definitive Agreement
12:00am
424B5
9c05g4u7
30 Apr 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
zdwsbh47f
16 Oct 09
Regulation FD Disclosure
12:00am
424B3
qv0dp
10 Apr 14
Prospectus supplement
12:00am
UPLOAD
977jz2tj2wd2ac3vde
8 Apr 19
Letter from SEC
12:00am
8-K
EX-99.1
6ccq7rgccjatk
16 Jan 07
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
0f8jm1a g66
25 Feb 10
Regulation FD Disclosure
12:00am
UPLOAD
ab7ea8sy3gv954ro wy
17 Apr 19
Letter from SEC
12:00am
UPLOAD
kwnr3vevd g2np1df
15 Feb 19
Letter from SEC
12:00am
8-K
pe65 wrgr
7 Jan 13
Regulation FD Disclosure
12:00am